|
Home About us Facilities Available Consultants Location Map Download Map Cashless Admissions Guidelines for patients Credits & Disclaimer Contact us
Specialities
ENT Gynaecology Keyhole surgeries Ophthalmology Paediatrics Infertility Pregnancy Delivery Breastfeeding Laparoscopy Pictures
| |
[ Basics about Infertility ] [ Intra-Uterine Insemination ] [ Polycystic Ovarian Syndrome ] [ Ovarian drilling for PCOS ] [ Ovulation Induction ]
What is
Polycystic Ovarian Syndrome (PCOS)?
PCOS is a health problem that can affect a woman’s menstrual cycle, fertility,
hormones, insulin production, heart, blood vessels, and appearance. Women with
PCOS have these characteristics:
* high levels of male hormones, also called androgens
* an irregular or no menstrual cycle
* may or may not have many small cysts in their ovaries. Cysts are fluid-filled
sacs.
PCOS is the most common hormonal reproductive problem in women of childbearing
age.
Polycystic ovary syndrome is
characterized by anovulation (irregular or absent menstrual periods) and
hyperandrogenism (elevated serum testosterone and androstenedione).
Patients with this syndrome may complain of abnormal bleeding, infertility,
obesity, excess hair growth, hair loss and acne. In addition to the clinical and
hormonal changes associated with this condition, vaginal ultrasound shows
enlarged ovaries with an increased number of small (6-10mm) follicles around the
periphery (Polycystic Appearing Ovaries or PAO). While ultrasound reveals
that polycystic appearing ovaries are commonly seen in up to 20% of women in the
reproductive age range, PolyCystic Ovary
Syndrome (PCOS) is a estimated to affect about half as many or
approximately 6-10% of women. The condition appears to have a genetic component
and those effected often have both male and female relatives with adult-onset
diabetes, obesity, elevated blood triglycerides, high blood pressure and female
relatives with infertility, hirsutism and menstrual problems.
Why do women with Polycystic
Ovarian Syndrome (PCOS) have trouble with their menstrual cycle?
The ovaries are two small
organs, one on each side of a woman's uterus. A woman's ovaries have follicles,
which are tiny sacs filled with liquid that hold the eggs. These sacs are also
called cysts. Each month about 20 eggs start to mature, but usually only one
becomes dominant. As the one egg grows, the follicle accumulates fluid in it.
When that egg matures, the follicle breaks open to release the egg so it can
travel through the fallopian tube for fertilization. When the single egg leaves
the follicle, ovulation takes place.
In women with PCOS, the ovary
doesn't make all of the hormones it needs for any of the eggs to fully mature.
They may start to grow and accumulate fluid. But no one egg becomes large
enough. Instead, some may remain as cysts. Since no egg matures or is released,
ovulation does not occur and the hormone progesterone is not made. Without
progesterone, a woman’s menstrual cycle is irregular or absent. Also, the cysts
produce male hormones, which continue to prevent ovulation.
| Normal Ovary |
Polycystic Ovary |
 |
 |
What are the symptoms of
Polycystic Ovarian Syndrome (PCOS)?
These are some of the symptoms of PCOS:
* infrequent menstrual periods, no menstrual periods, and/or irregular bleeding
* infertility or inability to get pregnant because of not ovulating
* increased growth of hair on the face, chest, stomach, back, thumbs, or toes
* acne, oily skin, or dandruff
* pelvic pain
* weight gain or obesity, usually carrying extra weight around the waist
* type 2 diabetes
* high cholesterol
* high blood pressure
* male-pattern baldness or thinning hair
HYPERINSULIN & PCOS?
As of yet, we do not understand why one woman who demonstrates polycystic
appearing ovaries on ultrasound has regular menstrual cycles and no signs of
excess androgens while another develops PCOS. One of the major biochemical
features of polycystic ovary syndrome is insulin resistance accompanied by
compensatory hyperinsulinemia (elevated fasting blood insulin levels).
There is increasing data that hyperinsulinemia produces the hyperandrogenism of
polycystic ovary syndrome by increasing ovarian androgen production,
particularly testosterone and by decreasing the serum sex hormone binding
globulin concentration. The high levels of androgenic hormones interfere with
the pituitary ovarian axis, leading to increased LH levels, anovulation,
amenorrhea, recurrent pregnancy loss, and infertility. Hyperinsulinemia has also
been associated high blood pressure and increased clot formation and appears to
be a major risk factor for the development of heart disease, stroke and type II
diabetes.
DIAGNOSIS
There is no single test to diagnose PCOS. Your doctor will take a medical
history, perform a physical exam—possibly including an ultrasound, check your
hormone levels, and measure glucose, or sugar levels, in the blood. If you are
producing too many male hormones, the doctor will make sure it’s from PCOS. At
the physical exam the doctor will want to evaluate the areas of increased hair
growth, so try to allow the natural hair growth for a few days before the visit.
During a pelvic exam, the ovaries may be enlarged or swollen by the increased
number of small cysts. This can be seen more easily by vaginal ultrasound, or
screening, to examine the ovaries for cysts and the endometrium. The endometrium
is the lining of the uterus. The uterine lining may become thicker if there has
not been a regular period. If you have irregular or absent menstrual periods,
clues from the physical exam will be considered next. Elevated androgen levels (male
hormones), DHEAS or testosterone help make the diagnosis. A two hour insulin
and glucose tolerance test will be obtained. Many physicians tell their patients
that insulin values are normal, when in fact the value indicates that insulin
may be playing a role in stimulating the development of PCOS. Most labs report
levels less than 25-30 miu/ml as normal, while in fact, levels over 10miu/ml on
a fasting blood sample suggests that PCOS may be related to hyperinsulinism.
 |
| Ultrasound picture of how a
polycystic ovary looks
|
Blood
hormone levels of LH, FSH, androgens and SHBG
Ideally, these
tests should be performed during the first four days of the cycle. If the women
has no period, then the test can be performed anytime, and repeated if the
results do not provide a clear picture.
FSH levels are
low or normal, LH levels are often raised. However, a normal level does not
exclude diagnosis of polycystic ovarian syndrome (PCOS). The levels of androgens
and testosterone may be raised.
The American
Society of Reproductive Medicine (ASRM) and the European Society of Human
Reproduction and Embryology (ESHRE) joint consensus meeting in November 2003
agreed that the diagnosis of PCOS should be made when two of the following three
criteria are met:
-
Infrequent or absent ovulation
-
Hyperandrogenism (clinical or
biochemical) such as excess hair growth, acne, raised LH, and raised androgen
index
-
Polycystic ovarian morphology
on ultrasound scan (>12 follicles measuring between 2 and 9mm in diameter)
and/or ovarian volume >10ml. The distribution of the follicles are not
required and with one ovary sufficient for diagnosis.
Does PCOS cause long-term
problems?
If you have PCOS, you are more likely to get high blood pressure or diabetes.
This means you have a greater risk for strokes and heart attacks.
Because of irregular menstrual periods, women with PCOS are more likely to be
infertile (unable to get pregnant). They may also have a higher risk for cancer
of the uterus or breast.
NEWER METHODS OF TREATMENT
Because there is no cure for
PCOS, it needs to be managed to prevent problems. Treatments are based on the
symptoms each patient is having and whether she wants to conceive or needs
contraception. Below are descriptions of treatments used for PCOS.
Birth control pills.
For women who don’t want to become pregnant, birth control pills can regulate
menstrual cycles, reduce male hormone levels, and help to clear acne. However,
the birth control pill does not cure PCOS. The menstrual cycle will become
abnormal again if the pill is stopped. Women may also think about taking a pill
that only has progesterone, like Provera, to regulate the menstrual cycle and
prevent endometrial problems. But progesterone alone does not help reduce acne
and hair growth.
If irregular and/or infrequent
menstruation is a problem, birth control pills that typically contain estrogen
and progestin can generally regulate your cycles. Restoring regular periods is
essential since it insures that the lining of the uterus is shed, protecting
against uterine cancer.
If you don't want to take a daily medication, talk to your doctor about a course
of progestogen (progesterone-like drugs) several times a year to start your
periods. It is important to have at least six to eight periods a year to promote
shedding of the endometrial lining; build up can lead to cancer.
Diabetes Medications.
The medicine, Metformin, also called Glucophage, which is used to treat type 2
diabetes, also helps with PCOS symptoms. Metformin affects the way insulin
regulates glucose and decreases the testosterone production. Abnormal hair
growth will slow down and ovulation may return after a few months of use. These
medications will not cause a person to become diabetic.
Fertility Medications.
The main fertility problem for women with PCOS is the lack of ovulation. Even
so, her husband’s sperm count should be checked and her tubes checked to make
sure they are open before fertility medications are used. Clomiphene (pills) and
Gonadotropins (shots) can be used to stimulate the ovary to ovulate. PCOS
patients are at increased risk for multiple births when using these medications.
In vitro Fertilization (IVF) is sometimes recommended to control the chance of
having triplets or more. Metformin can be taken with fertility medications and
helps to make PCOS women ovulate on lower doses of medication.
Ovulation Induction is
discussed in detail here.
Medicine for increased
hair growth or extra male hormones. If a woman is not trying to get
pregnant there are some other medicines that may reduce hair growth.
Spironolactone is a blood pressure medicine that has been shown to decrease the
male hormone’s effect on hair. Both of these medicines can affect the
development of a male fetus and should not be taken if pregnancy is possible.
Other non-medical treatments such as electrolysis or laser hair removal are
effective at getting rid of hair. A woman with PCOS can also take hormonal
treatment to keep new hair from growing.
Surgery.
Although it is not recommended as the first course of treatment, surgery called
ovarian drilling is available to induce ovulation. The
doctor makes a very small incision above or below the navel, and inserts a small
instrument that acts like a telescope into the abdomen. This is called
laparoscopy. The doctor then punctures the ovary
with a small needle carrying an electric current to destroy a small portion of
the ovary. Case series studies of women with PCOS have reported that ovarian
drilling results in an 80% ovulation rate and a 50% pregnancy rate. The
advantage of laparoscopy is that tubal patency can be checked at the same time
in a single procedure, and ovarian drilling of either one or both ovaries
appears to restore ovulation in a substantial number of patients. Serum
concentrations of LH and testosterone decrease rapidly after ovarian drilling
with a sustained mid- and long-term effect. The proportion of women with regular
menstrual cycles increases substantially after drilling and is sustained at
long-term follow-up. Ovulation and pregnancy rates are substantially increased
in the period after the operation and appear to be maintained. Resistance to the
effects of ovarian drilling include marked obesity, very elevated levels of
androgens, and long duration of infertility. Addition of other ovulating agents
such as clomiphene citrate or FSH appears to improve the effectiveness of
laparoscopic ovarian drilling
Summary of Ovarian Drilling:
| Indications |
- PCO patient undergoing a diagnostic
laparoscopy for tubal patency [tube testing]
- Clomiphene resistant patients
- Poor response to any ovulation
inducing drugs
|
| Techniques |
- Laser
- Cautery
- Multiple punch biopsies
|
| Clinical advantages |
- Improved endocrine profiles
- Spontaneous ovulation
- Reduction in gonadotropin doses for
ovulation induction and hence reduction in cost of further
stimulated cycles
- Improvement in pregnancy rates
- Reduction in multiple pregnancy
rates
- Reduction in first trimester
abortions
- Reduction in ovarian
hyperstimulation
|
| Clinical disadvantages |
- Possibility of adhesion formation
[reduced with instillation of plenty of fluids after the procedure]
- Possible compromise to ovarian
function and menopause at an earlier age but this is not confirmed
- Surgical and anaesthesia risk as
with any surgical procedure
|
A healthy weight.
Maintaining a healthy weight is another way women can help manage PCOS. Since
obesity is common with PCOS, a healthy diet and physical activity help maintain
a healthy weight, which will help the body lower glucose levels, use insulin
more efficiently, and may help restore a normal period. Even loss of 10% of her
body weight can help make a woman's cycle more regular.
For women in the reproductive
age range, polycystic ovary syndrome is a serious, common cause of infertility,
because of the endocrine abnormalities which accompany elevated insulin levels.
There is increasing evidence that this endocrine abnormality can be reversed by
treatment with widely available standard medications which are leading medicines
used in this country for the treatment of adult onset diabetes, metformin (Glucophage
500 or 850 mg three times per day or 1000mg twice daily with meals). These
medications have been shown to reverse the endocrine abnormalities seen with
polycystic ovary syndrome within two or three months. They can result in
decreased hair loss, diminished facial and body hair growth, normalization of
elevated blood pressure, regulation or menses, weight loss, reduction in
cardiovascular risk factors, normal fertility, and a reduced risk of
miscarriage. We have seen pregnancies result in less than two months in woman
who conceived in their very first ovulatory menstrual cycle. By six months over
90% of women treated with insulin-lowering agents, diet and exercise will resume
regular menses.
The medical literature suggests
that the endocrinopathy in most patients with polycystic ovary syndrome can be
resolved with insulin lowering therapy. This is clinically very important
because the therapy reduces hirsutism, obesity, blood pressure, triglyceride
levels, elevated blood clotting factors and facilitates reestablishment of the
normal pituitary ovarian cycle, thus often allowing resumption of normal
ovulatory cycles and pregnancy. We know the polycystic ovary syndrome is
associated with increased risk of heart attack and stroke because of the
associated heart attack and stroke risk factors, hypertension, obesity,
hyperandrogenism, hypertriglyceridemia, and these are to a large degree resolved
by therapy with these medications.
What is the most effective
therapy for an anovulatory patient with PCOS who wishes to become pregnant? It
is clear that lifestyle modification with caloric restriction and exercise is
extremely important in the first stage of any intervention. This should be
considered active medical therapy and not as an alternative to other medical
intervention. Once the patient has established adequate lifestyle change,
ovulations will either occur spontaneously with subsequent pregnancy or
additional intervention will be required. Clomiphene citrate is still considered
to be a cheap, safe, and easy alternative and would probably be the first-line
therapy for anovulatory PCOS. It could be argued, however, that at this stage
metformin is equally effective and is introduced initially at a low dose and
subsequently building up to 1500–2500 mg/d. Metformin alone can be considered an
effective form of therapy (Fig. 2Go). Failure to respond to clomiphene citrate
offers the options of laparoscopic drilling, addition of metformin, or the use
of gonadotropins.
ARE THESE MEDICATIONS SAFE?
Side effects are rare. Although metformin lowers elevated blood sugar levels in
diabetics, when given to nondiabetic patients, it only lower insulin levels.
Blood sugar levels will not change. In fact, episodes of "hypoglycemic attacks"
appear to be reduced.
METFORMIN (Glucophage):
When first starting this medication, people will often experience upset stomach
or diarrhea which usually resolves after the first week. This side effect can be
minimized by taking metformin with a meal and starting with a low dose. I
recommend that our patients start with one 500 mg pill daily the first week and
increase to twice a day during the second week. If after the second week GI side
effects are minimal, the dose is increased to 850 mg twice daily. Patients
taking metformin should notify their physician and discontinue the medication:
-
48 hours before surgery
-
48 hours before an IVP Xray study or other Xrays where an
intravenous dye is administered
-
If you experience shortness of breath, severe muscle
weakness or chest pain
-
If you use alcohol excessively
HOW DO WE MONITOR THERAPY?
BBT charts are monitored and reviewed to determine if you are ovulating, or
follicular monitoring may be carried out by ultrasonography. You will be asked
to return three months after initiating therapy. If you have ovulated, therapy
may be continued another three months to see if you will conceive. Re-evaluation
will include measurements of lab tests that were abnormal at the initial
evaluation. If the laboratory studies are still abnormal, metformin may be
increased up to 850 mg three times daily. If the laboratory studies are normal
but ovulation has not occured, a trial of letozole may be considered. We have
seen that women who were unable to ovulate on up to 250 mg of clomiphene ovulate
when very low doses of clomiphene or letrozole is used in conjunction with
metformin. Laparoscopic ovarian drilling may be considered for those women where
other indications for laparoscopy are present.
PREGNANCY
While safety during pregnancy has not yet been established, three patients who
continued on metformin during their entire pregnancy and one who remained on a
glitazone have delivered normal babies. There are no reports of abnormal babies
in women who conceived using metformin and all resulting babies were normal.
Metformin is a category B medication. This means that insufficient human data is
available but no credible animal data suggesting a teratogenic (could produce
birth defects) risk. Although to the best of our present knowledge the risk
of birth defects would be small, it must also be noted that maternal diabetes
has been associated with an increased risk of birth defects and the underlying
elevated insulin levels may lead to birth defects if not corrected.
While the most prudent policy
may be to avoid the use of these medications during pregnancy until more data on
pregnancy outcome is available, the risk of miscarriage may be reduced by
continuing metformin during the pregnancy.
MISCARRIAGE & PCOS
Women with PCOS who conceive either spontaneously or after ovulation induction
have a much higher risk of miscarriage. Liddell has shown that polycystic
appearing ovaries (on ultrasound) are more frequently seen in women with
recurrent pregnancy loss, the presence of PCO on ultrasound did not predict the
outcome in subsequent pregnancies. Hypersecretion of LH was thought to cause
chromosomally abnormal eggs leading to an increased risk of miscarriage. But a
Japanese study found that PCOS was more common in women whose prior loss was
associated with normal chromosomes. Others have suggested that high androgen
levels may be a contributory factor. Homburg has shown that miscarriage rates
after ovulation induction or IVF is decreased when women are pretreated with a
GnRH-agonist such as Synarel, Lupron or Zoladex.
Hyperinsulinemia may be a
contributing factor in the higher rate of miscarriage. Elevated levels of
insulin interfere with the normal balance between factors promoting blood
clotting and those promoting breakdown of the clots. There are no
placebo-controlled clinical trials to indicate whether pregnancy outcomes are
improved in pregnancies that result from the use of insulin-lowering medications
or whether pregnancy outcomes are better in those who continue metformin
throughout the pregnancy or those who discontinue.
|